Development of antigen&#160;capture ELISA for the quantification of EIAV p26 protein (Q41725988)

8 October 2017

Development of antigen capture ELISA for the quantification of EIAV p26 protein (English)

1 reference

8 October 2017

Zhe Hu

1

1 reference

8 October 2017

Hao Chang

2

1 reference

8 October 2017

Man Ge

3

1 reference

8 October 2017

Yuezhi Lin

4

1 reference

8 October 2017

Xuefeng Wang

5

1 reference

8 October 2017

Wei Guo

6

1 reference

8 October 2017

Xiaojun Wang

7

1 reference

8 October 2017

language of work or name

English

0 references

publication date

26 September 2014

1 reference

Applied Microbiology and Biotechnology

8 October 2017

1 reference

8 October 2017

98

1 reference

8 October 2017

9073-9081

1 reference

8 October 2017

21

1 reference

https://scigraph.springernature.com/pub.10.1007/s00253-014-6078-8

8 October 2017

0 references

cites work

Amplification of complete gag gene sequences from geographically distinct equine infectious anemia virus isolates

1 reference

https://api.crossref.org/works/10.1007%2FS00253-014-6078-8

Functional roles of equine infectious anemia virus Gag p9 in viral budding and infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-014-6078-8

Development of a multiplex real-time reverse transcriptase-polymerase chain reaction for equine infectious anemia virus (EIAV).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-014-6078-8

Lessons in AIDS vaccine development learned from studies of equine infectious, anemia virus infection and immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-014-6078-8

Development of a high throughput, semi-automated, infectious center cell-based ELISA for equine infectious anemia virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-014-6078-8

Production of Equine Infectious Anemia Virus (EIAV) antigen in Pichia pastoris

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-014-6078-8

Inhibition of virus replication and induction of human tetherin gene expression by equine IFN-α1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-014-6078-8

Continuous cultures of fused cells secreting antibody of predefined specificity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-014-6078-8

HIV requires multiple gp120 molecules for CD4-mediated infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-014-6078-8

Combined amino acid mutations occurring in the envelope closely correlate with pathogenicity of EIAV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-014-6078-8

Recommendations for the design and use of standard virus panels to assess neutralizing antibody responses elicited by candidate human immunodeficiency virus type 1 vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-014-6078-8

High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-014-6078-8

Real-time quantitative RT-PCR and PCR assays for a novel European field isolate of equine infectious anaemia virus based on sequence determination of the gag gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-014-6078-8

The immunopathogenesis of equine infectious anemia virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-014-6078-8

A transient three-plasmid expression system for the production of high titer retroviral vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-014-6078-8

Immune selection of equine infectious anemia virus env variants during the long-term inapparent stage of disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-014-6078-8

Multiplex immunoassays of equine virus based on fluorescent encoded magnetic composite nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-014-6078-8

Genomic comparison between attenuated Chinese equine infectious anemia virus vaccine strains and their parental virulent strains

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-014-6078-8

Unique evolution characteristics of the envelope protein of EIAV(LN₄₀), a virulent strain of equine infectious anemia virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-014-6078-8

Natural variation of equine infectious anemia virus Gag protein cytotoxic T lymphocyte epitopes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-014-6078-8

Restriction of equine infectious anemia virus by equine APOBEC3 cytidine deaminases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-014-6078-8

Amino acid mutations of the infectious clone from Chinese EIAV attenuated vaccine resulted in reversion of virulence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-014-6078-8

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-014-6078-8

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-014-6078-8

10.1007/S00253-014-6078-8

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

8 October 2017

0 references

1 reference